RAM
PRCT icon

Resona Asset Management’s Procept Biorobotics PRCT Stock Holding History

Resona Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,050
Closed -$230K – 833
2025
Q2 		$230K Sell
4,050
-100
-2% -$5.65K ﹤0.01% 742
2025
Q1 		$249K Sell
4,150
-1,873
-31% -$128K ﹤0.01% 732
2024
Q4 		$488K Sell
6,023
-477
-7% -$40.8K ﹤0.01% 714
2024
Q3 		$519K Buy
+6,500
New +$462K ﹤0.01% 714

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Resona Asset Management's PRCT Position: Q3 2025 in Review

Resona Asset Management sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 4,050 shares — an estimated $230K sold.

Resona Asset Management first reported a position in PRCT in Q3 2024 and held it in 4 quarters. The position peaked at $519K in Q3 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Resona Asset Management reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • Resona Asset Management sold 4,050 Procept Biorobotics shares in Q3 2025, an estimated $230K.
  • Resona Asset Management first reported a position in Procept Biorobotics in Q3 2024 and held it in 4 quarters.
  • Resona Asset Management's Procept Biorobotics position peaked at $519K in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Resona Asset Management's 13F filing for Q3 2025, filed 31 Oct 2025.